(Date:11/5/2009)...re-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) tod...uarter ended September 30, 2009. GenVec reported a...e three months ended September 30, 2009 compared t...the comparable quarter of 2008. For the nine month...$14.1 million ($0.15 per share), compared to a net...
(Date:11/5/2009)...er 5, 2009 at 4:30 p.m. Eastern Time , BOTHEL...- OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or ...udited financial results for the third quarter and... the Company,s highlights for the third quarter of...flect the operations of OncoGenex Technologies Inc...
(Date:11/5/2009)...Newswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNM...receptor-based technologies to discover novel flav...ent supply industries, today provided a corporate ...d quarter ended September 30, 2009. Revenues were...red to $4.0 million for the third quarter of 2008,...
(Date:11/5/2009)...nd vision correction experts listed in the Trusted...t the recently concluded American Academy of Ophth...o, California. Dr. Stephen Brint, MD, Dr. Frederic...Peter Rapoza, MD, Dr. Michael Raizman, MD, Dr. Jam...rd Manche, MD, and Dr. Parag Majmudar, MD, all lea...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9...GA, ON, Oct. 11 /PRNewswire-FirstCall/ - YM BioSci...logy company that identifies, develops,and commerc...wide, today,advised that its Annual Meeting of Sha...t 4:00pm at the Gallery of the TSX Broadcast & Con...t West, Toronto, Ontario. The items for considera...
... Oppose Proposal to Kill Human Embryos for Researc...ference President and Chief Executive Officer Sist...atement today regarding the formation of the,ballo...In order to protect human life at its most vulnera...ated, that seeks to clone and/or kill,human embryo...
...zerland, October 11 The young Swiss biotech,enter... Michel Klein, one,of the world,s most renowned va...ice President of Science & Technology of the Avent...ship of the scientific sector of,vaccine developme...as,access to an outstanding network across one of ...
Other Biology Technology:YM BIOSCIENCES NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND NOMINATION OF DIRECTORS 2YM BIOSCIENCES NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND NOMINATION OF DIRECTORS 3Prof. Michel Klein Becomes Chief Scientific Officer at AMVAC 2Chicken Anti-PSMD1 Polyclonal Antibody, Unconjugated from ProSci, Inc
Terrific Broth from GE Healthcare, formerly Amersham Biosciences
...ole 1200L sets the new standard for value in today...latest technologies and providing tailored solutio... The Atmospheric Pressure Ionization (API) interf...de superior selectivity and sensitivity for pharma...
Mouse Anti-Human beta IG-H3 Monoclonal Antibody, Unconjugated, Clone 348506 from R&D Systems
Biology Products: